Table 2.
Relative risk of MGUS and lymphoproliferative malignancies among first-degree relatives of MGUS patients
| First-degree relatives of MGUS patients (n = 14621) | First-degree relatives of controls (n = 58387) | RR (95% CI)* | |
|---|---|---|---|
| MGUS | 22 | 31 | 2.8 (1.4-5.6)† |
| Multiple myeloma | 41 | 57 | 2.9 (1.9-4.3)† |
| Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia | 8 | 8 | 4.0 (1.5-11)† |
| Chronic lymphocytic leukemia | 23 | 46 | 2.0 (1.2-2.3)† |
| Non-Hodgkin lymphoma | 44 | 161 | 1.1 (0.8-1.5) |
| Hodgkin lymphoma (< 45 y) | 8 | 24 | 1.3 (0.6-2.9) |
| Hodgkin lymphoma (> 45 y) | 1 | 18 | 0.2 (0.0-1.7) |
All estimates were adjusted for sex of first-degree relative.
Statistically significant (2-sided P value < .05).